Your browser doesn't support javascript.
loading
The JAK1/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release.
Hermans, Maud A W; Schrijver, Benjamin; van Holten-Neelen, Conny C P A; Gerth van Wijk, Roy; van Hagen, P Martin; van Daele, Paul L A; Dik, Willem A.
Afiliação
  • Hermans MAW; Department of Internal Medicine, Sections of Allergy and Clinical Immunology, Erasmus MC, Rotterdam, The Netherlands.
  • Schrijver B; Department of Immunology, Erasmus MC, Rotterdam, The Netherlands.
  • van Holten-Neelen CCPA; Laboratory Medical Immunology, Erasmus MC, Rotterdam, The Netherlands.
  • Gerth van Wijk R; Department of Immunology, Erasmus MC, Rotterdam, The Netherlands.
  • van Hagen PM; Laboratory Medical Immunology, Erasmus MC, Rotterdam, The Netherlands.
  • van Daele PLA; Department of Internal Medicine, Sections of Allergy and Clinical Immunology, Erasmus MC, Rotterdam, The Netherlands.
  • Dik WA; Department of Internal Medicine, Sections of Allergy and Clinical Immunology, Erasmus MC, Rotterdam, The Netherlands.
Clin Exp Allergy ; 48(11): 1412-1420, 2018 11.
Article em En | MEDLINE | ID: mdl-29939445
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Degranulação Celular / Citocinas / Janus Quinase 1 / Janus Quinase 2 / Mastócitos Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Degranulação Celular / Citocinas / Janus Quinase 1 / Janus Quinase 2 / Mastócitos Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article